Pharmacovigilance
Pharmacovigilance
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| Levofloxacin Sandoz (Levofloxacin) | 2020-09-13 | Systemic fluoroquinolones: risk of heart valve regurgitation |
|
| Esbriet® (Pirfenidone) | 2019-12-08 | Important Safety Update on ESBRIET® (pirfenidone) and Drug-Induced Liver Injury (DILI) |
|
| Xarelto ® (Rivaroxaban) | 2015-12-14 | Warnings and precautions for use to reduce the risk of bleeding.
|
|
| Valdoxan® - Agomelatine | 2014-03-19 | New contraindication for use and a reminder of importance of liver function monitoring. CLICK HERE |
|
| Roaccutane® - Isotretinoin | 2014-03-17 | Pregnancy Prevention Program and Safety Information about Roaccutane®. |
|
| VIREAD ® - Tenofovir | 2014-03-11 | Possible presence of silicone rubber in the above listed product and lots. |
|
| ZOFRAN® - Ondansetron | 2013-08-29 | Updated information on posology for intravenous use and dose dependant QT interval prolongation. |
|
| Diane-35® - Ethinylestradiol/Cyproterne | 2013-07-22 | Risk of Thromboembolism. |
|
| Cilest® - Ethinylestradiol, Norgestimate | 2013-07-08 | The reason for the recall is that dissolution testing of norgestimate.
|
|
| Solpadeine® - Paracetamol, Caffeine, Codeine Phosphate | 2013-05-07 | The use of codeine containing products for children after tonsillectomy and /or adenoidectomy surgery |
|